Latin-American position about current state of hormone therapy;Posición Latinoamericana en relación con el estado actual de la terapia hormonal

Ginecologia y Obstetricia de Mexico

Volumn 73, Issue 4, 2005, Pages 205-211

  Figueroa Casas, Pedro ^a   Siseles, Néstor ^b   Aurélio Albernaz, Marco ^c,d   Chada Baracat, Edmund ^d,e   Barbosa, Ione Cristina ^f   Bossemeyer, Ronald ^g,h   Fernandes, César Eduardo ⁱ   Maia Filho, Hugo ^f,j   De Melo, Nilson R ^k   Rodrigues De Lima, Geraldo ^e,l   Monterrosa Castro, Álvaro ^m,n   González Campos, Oscar ^o   Carranza Lira, Sebastián ^p   Espinosa Larrañaga, Francisco ^q   Hernández Bueno, Alberto ^d,r   Murillo Uribe, Alfonso ^s   Santos González, Javier ^d   Molina Vilchez, Rafael ^d  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c Hospital Materno Infantil de Goiânia   (Brazil)

^d Comité Directivo de la Sociedad Brasileña de Climaterio ^*  (Venezuela)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^g Universidad Federal de Santa Maria   (Brazil)

^h Academia de Medicina   (Brazil)

ⁱ FACULDADE DE MEDICINA DO ABC   (Brazil)

^j Centro de Pesquisa y Asistencia en Reproducción Humana   (Brazil)

^k UNIVERSITY OF SÃO PAULO   (Brazil)

^l Hospital dos Servidores de São Paulo   (Brazil)

^m UNIVERSIDAD DE CARTAGENA   (Colombia)

ⁿ Asociación Colombiana de Menopausia   (Colombia)

^o HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^p INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^q INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^r Asociacion Mexicana para el Estudio del Climaterio   (Mexico)

^s FRACYM ^*  (Mexico)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; MENOPAUSAL SYNDROME; MONOTHERAPY; SOUTH AND CENTRAL AMERICA;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COLONIC NEOPLASMS; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LATIN AMERICA; MENOPAUSE; OSTEOPOROSIS, POSTMENOPAUSAL; PROGESTINS; RISK ASSESSMENT;

EID: 33646473160     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kronenberg F. Hot flashes. In: Lobo RA, editor. Treatment of the Post Menopausal Woman. Philadelphia: Lippincott William & Wilkins, 1999;pp:157-77.
2. Randoph JF, Sowers M, Gold EB, et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size and menopausal status. J Clin Endocrinol Metab 2003;88:1516-22.
3. Kronenberg F, Barnard RM. Modulation of menopausal hot flashes by ambient temperature. J Therm Biol 1992;17:43-49.
4. Rossouw JE, Anderson GL, Prentice RL, et al. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
5. Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-34.
6. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative Randomized Trial. JAMA 2003;289:3243-53.
7. Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419-27.
8. Fernandes CE, Soares-Pereira A, Bonassi-Machado R, et al. Consenso da SOBRAC-Associaçao Brasileira de Climatério. Terapeutica Hormonal na pero e na pós-menopausa. Cap. 7. Sao Paulo: Medcomm, 2004.
9. Basavilvazo MA, Bravo-Rodriguez LM, Carranza-Lira S, et al. Primer Consenso Nacional Multidisciplinario sobre Terapia de Reemplazo Hormonal. Rev del Clim 2004;7(40):156-79.
10. Campodónico I, Siseles N, Gutiérrez P, Belardo A, et al. Consenso Latinoamericano sobre Terapia Hormonal Postmenopáusica (Memoria Mecanograma). Salta, Argentina 14-15 de agosto del 2003.
11. Research Group. Heart Estrogen/progestin Replacement Study (HERS). JAMA 1998;280:605-13.
12. Research Group. Heart Estrogen/progestin Replacement Study (HERS II). JAMA 2002;288:49-57.
13. Herrington DM, et al. Estrogen Replacement and Atherosclerosis Study (ERAS). N Engl J Med 2000;343:522-9.
14. Grodstein F, Stamfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-61.
15. Guidelines for the hormone treatment of women in the menopausal transition and beyond. Position Statement by the Executive Committee of the International Menopause Society. Climacteric 2004;7:8-11.
16. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12.
17. th Workshop of the International Menopause Society. London: Parthenon Publishing, 2004;pp:166-74.
18. Aksel S, Schomberg DW, Tyrey L, Hammond CB. Vasomotor symptoms, serum estrogen and gonadotropin levels in surgical menopause. Am J Obstet Gynecol 1976;126:165-9.
19. Hutton JD, Jacobs HS, Murray MAF, James VHT. Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet 1978;1:671-81.
20. North American Menopause Society. Estrogens and Progestogen use in peri and postmenopausal women. September 2003. Position Statement of the North American Menopause Society. Menopause 2003;10:497-506.
21. North American Menopause Society. Treatment of menopause associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause 2004;11:11-33.
22. MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes (Cochrane Review). Cochrane Database Syst Rev 2001;1:CD002978.
23. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 2000;356:2059-63.
24. Stearns V, Issacs C, Rowland J, et al. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol 2000;11:17-22.
25. Loprinzi L, Barton DL, Sloan JA, et al. Pilot evaluation of gabapentin for treatment hot flashes. Mayo Clin Proc 2002;77:1159-63.
26. Nesheim BI, Saetre T. Reduction of menopausal hot flashes by methyldopa: a double blind crossover trial. Eur J Clin Pharmacol 1981;20:413-6.